Study
One
Study
One
Study
Two
Study
Two
Study
Three
Study
Three
APPLICATIONS
LAB282 welcomes ad hoc applications, as well as applications in response to specific calls that it may issue.
LAB282 SUPPORT
LAB282 helps academics access a wide range of early stage drug discovery and development capabilities.
LAB282 TEAM
Thomas Hanke, our Expert in Residence, works in cross-functional teams setting directions and fostering innovation.